［7］ Sakamoto T, Saiura A, Ono Y, et al. Optimal lymphadenectomy for duodenal adenocarcinoma：外科治療 CQ2 61［5］ Onkendi EO, Boostrom SY, Sarr MG, et al. 15—year experience with surgical treatment of duode-nal carcinoma：a comparison of periampullary and extra—ampullary duodenal carcinomas. J Gas-trointest Surg. 2012；16：682—691.［6］ Jiang QL, Huang XH, Chen YT, et al. Prognostic factors and clinical characteristics of patients with primary duodenal adenocarcinoma：a single—center experience from China. Biomed Res Int. 2016：6491049.does the number alone matter? Ann Surg Oncol. 2017；24：3368—3375.［8］ Debang Li, Si X, Wan T, et al. Outcomes of surgical resection for primary duodenal adenocarcino-ma：a systematic review. Asian J Surg. 2019；42：46—52.［9］ Lee CHA, Shingler G, Mowbray NG, et al. Surgical outcomes for duodenal adenoma and adenocar-cinoma：a multicentre study in Australia and the United Kingdom. ANZ J Surg. 2018；88：157—161.［10］ Sohn TA, Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum：factors influencing long—term survival. J Gastrointest Surg. 1998；2：79—87.［11］ Kohga A, Yamamoto Y, Sano S, et al. Surgical strategy for T1 duodenal or ampullary carcinoma according to the depth of tumor invasion. Anticancer Res. 2017；37：5277—5283.［12］ Adriano T, Mazzoni G, Puma F, et al. Adenocarcinoma of the third and fourth portions of the duo-denum：results of surgical treatment. Arch Surg. 2003；138：80—85.
元のページ ../index.html#14